John Cox, EVP Pharmaceutical Oper & Technology at BIOGEN IDEC INC. (BIIB), sold 1,125 shares at $63.04 ($71K) on 2010-11-02, disclosed to the SEC on 2010-11-03.
Scheduled sale ($71k) by EVP Pharmaceutical Oper & Technology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.55 | 360 | $23K | 31.8% |
| 2 | $63.04 | 765 | $48K | 68.2% |
| Total | $62.88 avg | 1,125 | $71K | 100% |
| Filing → |
| DYN | SELL | 2026-06-17 | $49K | — | Filing → |
| DYN | SELL | 2026-05-14 | $61K | — | Filing → |
| DYN | SELL | 2026-03-06 | $41K | — | Filing → |